Skip to main content
Top

The relationship between motoric cognitive risk syndrome and all-cause mortality in older people: findings from CHARLS 2011–2023

  • Open Access
  • 09-12-2025
  • Research
Published in:

Abstract

Background

This study aims to investigate the association between motoric cognitive risk (MCR) syndrome, defined by the coexistence of slow gait and subjective cognitive complaints, and all-cause mortality among older adults in China, providing evidence to support early identification and intervention strategies for MCR in aging populations.

Methods

Data were drawn from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2023), including 6,304 participants aged 60 years and older. A Cox proportional hazards model was used to examine the association between MCR and all-cause mortality, adjusting for demographic characteristics, lifestyle behaviors, health status, chronic diseases, and metabolic biomarkers.

Results

The study found an association between MCR and all-cause mortality in older adults. Among the participants, 15.5% (934/6,304) died during the follow-up period, with 20.9% (256/1,227) from the MCR group and 13.4% (678/5,077) from the non-MCR group. The median follow-up time was 144 months in the MCR group and 120 months in the non-MCR group. The Cox proportional hazards model indicated that MCR was associated with a higher risk of all-cause mortality (HR = 1.54, 95% CI: 1.34–1.78), and this association remained significant after adjusting for all confounders (HR = 1.46, 95% CI: 1.27–1.70).

Conclusion

This study confirms that MCR is associated with an increased risk of all-cause mortality in older people.
Title
The relationship between motoric cognitive risk syndrome and all-cause mortality in older people: findings from CHARLS 2011–2023
Authors
Xiang Li
Chao Wei
Kejing Hu
Jie Sun
Xiang Gao
Jianhong Yang
Publication date
09-12-2025
Publisher
BioMed Central
Published in
Archives of Public Health / Issue 1/2026
Electronic ISSN: 2049-3258
DOI
https://doi.org/10.1186/s13690-025-01807-w
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video

Keynote webinar | Spotlight on innovations in retinal disease

Retinal diseases are a significant cause of vision impairment and blindness worldwide, but the diagnostic and treatment landscape is rapidly evolving. Explore groundbreaking advances in retinal imaging and gene therapy, before taking a deep dive into emerging treatments for wet AMD.

Prof. Giuseppe Querques
Prof. Dr.med. Katarina Stingl
Dr. Miklos Schneider
Watch now
Video
Image Credits
Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images, Close-up of eye during optical coherence tomography for high-resolution retinal imaging and diagnostics/© Lucija / Generated with AI / Stock.adobe.com (symbolic image with model)